Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2020
Home
2020
April 27, 2020
Published by
Tiffany McMillan
on
April 27, 2020
Categories
Cellmid Appendix 4C – Q3 FY2020 business activity
April 22, 2020
Published by
Tiffany McMillan
on
April 22, 2020
Categories
Notice of May 2020 General Meeting
April 22, 2020
Published by
Tiffany McMillan
on
April 22, 2020
Categories
Independent test results for the Wondfo Sars-Cov2 Test
April 17, 2020
Published by
Tiffany McMillan
on
April 17, 2020
Categories
Share Purchase Plan
April 14, 2020
Published by
Tiffany McMillan
on
April 14, 2020
Categories
Cellmid’s shipment of Sars-Cov2 test received
April 14, 2020
Published by
Tiffany McMillan
on
April 14, 2020
Categories
Appendix 2A – Application for quotation of +securities
April 14, 2020
Published by
Tiffany McMillan
on
April 14, 2020
Categories
Market Release – Pause in Trading
April 8, 2020
Published by
Tiffany McMillan
on
April 8, 2020
Categories
An offer of +securities under a +securities purchase plan
April 7, 2020
Published by
Tiffany McMillan
on
April 7, 2020
Categories
Cellmid Limited (ASX: CDY) – Reinstatement to Official Quotation
Prev page
1
2
3
4
5
6
7
8
9
Next page
